Vincristine and Ondansetron Do Not Cause Vasodilation; Methotrexate Has No Direct Vasodilatory Effects
None of these three medications—vincristine, methotrexate, or ondansetron—cause vasodilation. In fact, vincristine can cause hypertension and hypotension through autonomic dysfunction, not vasodilation.
Vincristine: Causes Hypertension and Hypotension (Not Vasodilation)
Vincristine's cardiovascular effects are the opposite of vasodilation:
- The FDA label explicitly states that vincristine causes both hypertension AND hypotension 1
- These blood pressure changes result from autonomic nervous system dysfunction (neurotoxicity), not from direct vascular effects
- One case report documented severe orthostatic hypotension during vincristine therapy that resolved when the drug was discontinued 2—this was due to autonomic neuropathy affecting blood pressure regulation, not vasodilation
- The guideline literature confirms vincristine's neurotoxic profile but makes no mention of vasodilatory properties 3, 4, 5, 6, 7
Clinical pitfall: The hypotension seen with vincristine is NOT from vasodilation—it's from autonomic nerve damage affecting the body's ability to regulate blood pressure normally. This is a critical distinction because the management differs entirely.
Methotrexate: No Vasodilatory Effects
Methotrexate has an extensive adverse effect profile, but vasodilation is not among them:
- The FDA label lists cardiovascular effects as pericarditis, pericardial effusion, hypotension, and thromboembolic events—but NOT vasodilation 8
- The hypotension mentioned occurs through different mechanisms (likely related to systemic toxicity or fluid shifts), not direct vasodilation
- Multiple guidelines using methotrexate in ALL, Crohn's disease, and other conditions make no reference to vasodilatory effects 4, 5, 6, 9, 7, 10
Ondansetron: No Vasodilatory Properties
Ondansetron is a 5-HT3 receptor antagonist used for nausea/vomiting:
- There is no evidence in the provided literature that ondansetron causes vasodilation
- One recent guideline mentions ondansetron in the context of amniotic fluid embolism treatment, but specifically notes that "serotonin antagonism with ondansetron manifests limited hemodynamic consequence" 11
- Ondansetron is successfully used to prevent methotrexate-induced nausea without reports of vasodilatory effects 12
What Actually Causes Vasodilation in Oncology Settings
If you're concerned about vasodilation in patients receiving these chemotherapy agents, consider:
- Corticosteroids (often given with these regimens) can affect vascular reactivity, though they typically enhance vasoconstriction rather than cause vasodilation 13
- Sepsis or cytokine release syndrome from the underlying disease or treatment
- Other supportive medications in the treatment regimen
Bottom line: None of these three drugs cause vasodilation. Vincristine causes blood pressure instability through neurotoxicity, while methotrexate and ondansetron have no direct vasodilatory effects.